The FDA is reportedly planning to assess data on possible presence of chemical 4-MeI, a carcinogenic byproduct, produced at the time of manufacturing of caramel colored soda, after a Consumer Reports test indicated higher levels of carcinogen in sodas selling across the U.S.
Consumer Reports and Johns Hopkins Center for a Livable Future joined hands to test samples of soda brands for 4-MeI levels in California and New York twice last year.
A California measure was used to test brands like Pepsi, Coca-Cola, and Malta Goya, out of which, Malta Goya reported ten times more carcinogen than the accepted amount, reaching up to 300 micrograms, Verge reported.
Meanwhile, FDA continues to maintain that there is no reason to believe the compound is unsafe. However, it did say that it will look into the matter.
In 2007, the National Toxicology Program, a branch of the US Department of Health and Human Services had said that the 4-MeI substance that caused cancer in mice could be "possibly carcinogenic" to humans.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
